December 16, 2016
Astellas Pharma, Daiichi Sankyo, and Kobe-based device and diagnostics firm Sysmex said on December 15 that they have signed a memorandum of understanding to create a method for analyzing circulating tumor cells (CTCs). Under the deal, they will work to...read more